1. Yuan, Shuai, Wang, Lijuan, Zhang, Han, Larsson, Susanna C, Li, Xue. 2023. Mendelian randomization and clinical trial evidence supports TYK2 inhibition as a therapeutic target for autoimmune diseases. In EBioMedicine, 89, 104488. doi:10.1016/j.ebiom.2023.104488. https://pubmed.ncbi.nlm.nih.gov/36842216/
2. Dendrou, Calliope A, Cortes, Adrian, Shipman, Lydia, McVean, Gil, Fugger, Lars. . Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity. In Science translational medicine, 8, 363ra149. doi:. https://pubmed.ncbi.nlm.nih.gov/27807284/
3. Chandra, Vikash, Ibrahim, Hazem, Halliez, Clémentine, Eizirik, Decio L, Otonkoski, Timo. 2022. The type 1 diabetes gene TYK2 regulates β-cell development and its responses to interferon-α. In Nature communications, 13, 6363. doi:10.1038/s41467-022-34069-z. https://pubmed.ncbi.nlm.nih.gov/36289205/
4. Gong, Xiaoyan, Ren, Fukai. 2022. Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients-An Integrated Bioinformatics Approach. In Disease markers, 2022, 5239033. doi:10.1155/2022/5239033. https://pubmed.ncbi.nlm.nih.gov/35711568/
5. Karjalainen, Anzhelika, Shoebridge, Stephen, Krunic, Milica, Strobl, Birgit, Müller, Mathias. 2020. TYK2 in Tumor Immunosurveillance. In Cancers, 12, . doi:10.3390/cancers12010150. https://pubmed.ncbi.nlm.nih.gov/31936322/
智鼠故事 
